RITUXIMAB IN A RISK-ADAPTED TREATMENT STRATEGY GIVES EXCELLENT THERAPEUTIC RESULTS IN NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA
BRITISH JOURNAL OF HAEMATOLOGY(2017)
关键词
nodular lymphocyte-predominant Hodgkin lymphoma,rituximab,risk-adapted therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要